Cerebral Oxygen Saturation Monitoring During Optimum Cord Management in Preterm Infants
NCT ID: NCT06526091
Last Updated: 2024-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40 participants
OBSERVATIONAL
2023-02-15
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cerebral Oxygenation to Guide Supplemental Oxygen
NCT02017691
Cerebral Oxygenation to Guide Medical Interventions in Extremely Preterm Infants
NCT01530360
Neonatal Cerebral Oxygenation After Exposure to Oxygen Evaluated With the INVOS Oximeter
NCT01690650
Measurement of the Effect of Positional Changes on Cerebral Oxygenation in Preterm Infants
NCT01255189
Neonatal Brain Oxygenation Study
NCT04439968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study aims to assess the feasibility of using the INVOS 5100 NIRS monitor immediately after delivery in preterm infants born before 34 weeks gestational age. The investigators aim to assess if they can generate meaningful data on brain oxygen levels in the first few minutes of life. The secondary objectives are to use this data to describe the changes in heart rate, peripheral oxygen and cerebral oxygen saturations during placental transfusion and cord clamping.
The investigators will use the INVOS device to measure cerebral oxygenation immediately after delivery, during placental transfusion and cord clamping. We will assess the feasibility of the INVOS device for this purpose. We will use the INVOS data and routinely collected data at delivery to evaluate the effect of optimum cord management on cerebral perfusion, heart rate and peripheral oxygen saturations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Preterm infants
Preterm infants born at less than 34 completed weeks gestation
Cerebral NIRS monitoring at delivery
Application of cerebral NIRS monitoring immediately after delivery and during optimum cord management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cerebral NIRS monitoring at delivery
Application of cerebral NIRS monitoring immediately after delivery and during optimum cord management
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parental consent
Exclusion Criteria
* Infants for whom resuscitation at birth is not appropriate
* Antenatal or immediate postnatal diagnosis of severe congenital anomaly
* Infants with complex congenital cardiac disease
1 Minute
24 Hours
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College Healthcare NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jayanta Banerjee, MD (Res)
Role: PRINCIPAL_INVESTIGATOR
Imperial College Healthcare NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College Healthcare NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22QC7933
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.